CLINICAL_TRIALS
trial_result
· 2012-04-19
Clinical Trial Update: Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED) [Phase 2]
Summary
The document reports the completed Phase 2 Merck trial MK-0000-111 for carotid atherosclerosis with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Carotid Atherosclerosis | Phase 2 | Status: COMPLETED | Results posted: 2012-04-19